Login / Signup

The Czech Experience with Eculizumab in Severe Paediatric Shiga Toxin-Producing Escherichia coli-Associated Haemolytic Uremic Syndrome Patients.

Patrik KonopasekJan DavidMonika MarejkovaNadezda SimankovaKarel VondrakJakub Zieg
Published in: Klinische Padiatrie (2020)
Keyphrases
  • escherichia coli
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • emergency department
  • prognostic factors
  • klebsiella pneumoniae
  • patient reported outcomes
  • biofilm formation
  • cystic fibrosis